Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)

R Lo Dico; M Faron; Y Yonemura; O Glehen; M Pocard; A Sardi; M Hübner; D Baratti; G Liberale; A Kartheuser; I de Hingh; P Sugarbaker; W Ceelen; B Moran; M Robella; F Quenet; L Sideris; D Goere; M Limbert; P Sammartino; D Morris; PSOGI Working Group, BIG RENAPE Working Group

doi:10.1016/j.ejso.2020.07.038

Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI)

Eur J Surg Oncol. 2021 Jan;47(1):89-100. doi: 10.1016/j.ejso.2020.07.038. Epub 2020 Aug 26.

Authors

R Lo Dico¹, M Faron², Y Yonemura³, O Glehen⁴, M Pocard⁵, A Sardi⁶, M Hübner⁷, D Baratti⁸, G Liberale⁹, A Kartheuser¹⁰, I de Hingh¹¹, P Sugarbaker¹², W Ceelen¹³, B Moran¹⁴, M Robella¹⁵, F Quenet¹⁶, L Sideris¹⁷, D Goere², M Limbert¹⁸, P Sammartino¹⁹, D Morris²⁰; PSOGI Working Group, BIG RENAPE Working Group

Collaborators

PSOGI Working Group, BIG RENAPE Working Group:
J Abba²¹, K Abboud²², C Arvieux²¹, S Carrere²³, O Facy²⁴, G Ferron²⁵, G Lorimier²⁴, F Marchal²⁶, P Rat²⁴, J-J Tuech²⁷, Laurent Villeneuve²⁸, P Ortega-Deballon²⁴

Affiliations

¹ Department of Digestive and Oncological Surgery, Lariboisière Hospital, AP-HP, INSERM Unit U1275 / CAP Paris-Tech, Université Sorbonne Paris Cité, Paris, France. Electronic address: rea.lo-dico@aphp.fr.
² Department of Surgical Oncology and INSERM Unit 1018 CESP Oncostat, Gustave Roussy, Villejuif, France.
³ Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, 4-27-1 Kamori-Cho, Kishiwada City, Osaka, 596-8522, Japan.
⁴ Department of Surgical Oncology, Hospices Civils de Lyon, Lyon Sud Hospital, Faculty of Medicine, France.
⁵ Department of Digestive and Oncological Surgery, Lariboisière Hospital, AP-HP, INSERM Unit U1275 / CAP Paris-Tech, Université Sorbonne Paris Cité, Paris, France.
⁶ The Institute for Cancer Care, Mercy Medical Center, Baltimore, MD, USA.
⁷ Department of Visceral Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Switzerland.
⁸ Peritoneal Surface Malignancies Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
⁹ Department of Surgery, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
¹⁰ Department of Abdominal Surgery and Transplantation, Colorectal Surgery Unit, Saint-Luc University Hospital, Université Catholique de Louvain (UCL), Belgium.
¹¹ Department of Surgery, Catharina Hospital, P.O. Box 1350, 5602ZA, Eindhoven, Netherlands.
¹² Program in Peritoneal Surface Oncology, MedStar Washington Hospital Center, 106 Irving Street NW, Suite 3900, Washington, DC, 20010, USA.
¹³ Department of Gastrointestinal Surgery, Ghent University Hospital, Belgium.
¹⁴ Peritoneal Malignancy Institute Basingstoke, Hampshire Hospitals Foundation Trust, Adelmaston Road, Basingstoke, RG24 9NA, UK.
¹⁵ Unit of Surgical Oncology, Candiolo Cancer Institute, IRCCS - FPO, Candiolo, Italy.
¹⁶ Department of Surgery, Montpellier Cancer Institute, France.
¹⁷ Department of Surgery, Hospital Maisonneuve-Rosemont, University de Montreal, Quebec, Canada.
¹⁸ IPO, Cirurgia Geral e Proctologia, Hospital Lusíadas Lisboa, Portugal.
¹⁹ Department of Surgery Pietro Valdoni, Sapienza University of Rome, Italy.
²⁰ Department of Surgery, Peritonectomy Center, St George Hospital, Gray St Kogarah, Sydney, NSW, 2217, Australia.
²¹ Department of Surgical Oncology, CHU Grenoble University, Grenoble, France.
²² Department of General Surgery, Centre Hospitalier Universitaire, Jean Monnet University, Saint Étienne, France.
²³ Department of Surgical Oncology, Institut du Cancer de Montpellier, Montpellier, France.
²⁴ Department of Surgical Oncology, CHU Dijon, Dijon, France.
²⁵ Department of Surgical Oncology, IUCT Oncopole, Toulouse, France.
²⁶ Department of Surgical Oncology, Institut de Cancerologie de Lorraine, Vandoeuvre-les-Nancy, France.
²⁷ Department of Digestive Surgery, Charles Nicolle University Hospital, Rouen, France.
²⁸ Department of Surgical Oncology, Hospices Civils de Lyon, France.

PMID: 32943276
DOI: 10.1016/j.ejso.2020.07.038

No abstract available

Publication types

Multicenter Study

MeSH terms

Aged
Cisplatin / administration & dosage
Colorectal Neoplasms / pathology*
Combined Modality Therapy
Cytoreduction Surgical Procedures*
Female
Humans
Hyperthermic Intraperitoneal Chemotherapy*
Male
Middle Aged
Mitomycin / administration & dosage
Neoplasm Grading
Neoplasm Staging
Peritoneal Neoplasms / secondary*
Peritoneal Neoplasms / therapy*
Postoperative Complications
Prospective Studies

Substances

Mitomycin
Cisplatin